We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Pre-designed CompoZr® Knockout Zinc Finger Nucleases for Entire Human Genome
Product News

Pre-designed CompoZr® Knockout Zinc Finger Nucleases for Entire Human Genome

Pre-designed CompoZr® Knockout Zinc Finger Nucleases for Entire Human Genome
Product News

Pre-designed CompoZr® Knockout Zinc Finger Nucleases for Entire Human Genome


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Pre-designed CompoZr® Knockout Zinc Finger Nucleases for Entire Human Genome"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The new offer can generate permanent and heritable gene knockouts in human cell lines within weeks.

Currently, few laboratories create gene knockouts in human cell lines because the inefficiencies of the natural cellular homologous recombination system and the investment of time and labor required to screen the resulting cells. In contrast, a wealth of peer-reviewed literature has shown that CompoZr ZFNs efficiently generate human cell lines with precise and stable gene knockouts in matter of weeks.1

“Sigma Life Science has worked diligently to develop predesigned CompoZr Knockout ZFNs for each gene in the human genome to make this ground breaking technology more readily available to the research community,” said David Smoller, Chief Scientific Officer of Sigma Life Science. “Researchers can select a ZFN from our library and swiftly knockout their target gene in any human cell line.”

In this new offering, Sigma has designed CompoZr ZFNs that will produce a knockout in each gene by inducing a double-strand break at a defined site within the gene’s first three exons. This double strand break stimulates the cell's natural DNA repair pathways, resulting in a permanent, site-specific deletion or mutation that disrupts the gene’s function. Robust and on-target gene knockout using CompoZr Knockout ZFNs is guaranteed by functional validation prior to shipment and unique enhancements to the DNA-recognition and cleavage ZFN subunits.
Advertisement